Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 2.2% | n/a |
ROCE | 2.8% |
Latest | F'cast | |
---|---|---|
P/E | 27.2 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 3.4 | n/a |
Pr/Book | 3.8 |
Latest | F'cast | |
---|---|---|
Revenue | 96.5% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 204.89 | (141.10) | (16.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 227.98 | (189.73) | (18.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 356.13 | (215.74) | (0.25)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 426.41 | (410.42) | (43.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 838.00 | 58.31 | 12.00¢ | 30.9 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Total Voting Rights | 30-Aug-2024 | 09:30 | RNS |
Update on Fruquintinib for Gastric Cancer in China | 30-Aug-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 22-Aug-2024 | 09:30 | RNS |
Chinese medicine firm employs Cambridge Universi... | 23-Dec-2009 | Guardian |
Joint venture offers food for growth | 09-Oct-2009 | The Scotsman |
Chi-Med unveils maiden profit | 31-Jul-2009 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 250.00p |
Change Today | -11.00p |
% Change | -4.21 % |
52 Week High | 352.00 |
52 Week Low | 192.40 |
Volume | 173,728 |
Shares Issued | 871.47m |
Market Cap | £2,178.67m |
Beta | 0.02 |
RiskGrade | 226 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 37,983 @ 249.95p |
16:35 | 44,231 @ 250.00p |
16:35 | 1,419 @ 250.00p |
16:35 | 676 @ 250.00p |
16:35 | 5,450 @ 250.00p |
You are here: research